AlphaSense makes it easy for you to keep a pulse on clinical trials and disease landscapes so you can inform every decision throughout a drug’s lifecycle—from identifying targets and licensing opportunities to commercialization strategies.
Start a free trialMonitor research from Wall Street’s top analysts, as well as ClinicalTrials.gov, PubMed, transcripts, filings and more—all in one place.
Our AI search technology and real-time alerts enable you to always stay on top of the latest movements.
Save time and get smarter faster by easily extracting relevant insights from high-value sources.
I was able to meet every deadline – which I couldn’t believe myself. When you use tools like [AlphaSense] to your benefit, you can be a much bigger program than you actually are.”
AlphaSense reduces our research time, and we’re able to re-allocate our time to engaging people in concepts and ideas—and in doing so, add more value to our company.”
CLINICAL PIPELINE TRACKING
Track and analyze clinical pipelines more easily with our aggregated universe of regulatory healthcare content from ClinicalTrials.gov, FDA, EMA, PubMed, and more.
DISEASE LANDSCAPING
Perform a more comprehensive competitor pipeline analysis and disease research to ensure you never miss out on updates with AI-powered company recognition and Search Summaries.
DUE DILIGENCE
Accelerate the market landscaping process by quickly uncovering TAM, understanding the competitive landscape and core differentiators.
EARNINGS ANALYSIS
Identify shifts in commentary, report on KPIs and themes competitors are discussing, surface emerging topics from industry leaders, and more.
Robust and helpful tool
“[What I like best] is the speed at which I can conduct my research and the confidence it gives me in knowing whether there is information available on a given topic.”
See our reviews
Whitepaper
Get started with a free trial of AlphaSense. Rapidly search an extensive universe of public and private content—broker research, regulatory healthcare content, earnings transcripts, company filings, trade journals, and more.